Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

U.S. Food and Drug Administration's Decision Regarding Bioequivalence of Levothyroxine Sodium

Thyroid®

Impact Factor: 6.6 / 5-Year Impact Factor: 6.5

Journal Homepage Submission guidelines

Restricted access

Brief report

First published online July, 2004

U.S. Food and Drug Administration's Decision Regarding Bioequivalence of Levothyroxine Sodium

Volume 14, Issue 7

https://doi.org/10.1089/1050725041517138

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

Response to Drs Maden and Page

Restricted access

Heart Rate and Metabolic Response to Burn Injury in Humans

Restricted access

Effect of an Elemental vs a Complex Diet on Polyamine Metabolism in Rat Isolated Enterocytes

Restricted access

Is Muscle Protein Turnover Regulated by Intracellular Glutamine During Sepsis?